Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1

Interventions

Ifosfamide 30 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 cabozantinib 9 apatinib 9 Specimen Handling 9 Carboplatin 9 fludarabine 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Biopsy 7 Topotecan 6 Mesna 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × penpulimab × Clear all

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡